沃华医药：前三季度净利润同比增长179.34%

Core Insights - The company reported a revenue of 625 million yuan for the first three quarters of 2025, representing a year-on-year growth of 8.31% [1] - The net profit attributable to shareholders reached 63.99 million yuan, showing a significant year-on-year increase of 179.34% [1] - In the third quarter, the company achieved a revenue of 199 million yuan, which is a year-on-year growth of 9.77%, with a net profit of 19.32 million yuan, reflecting a year-on-year increase of 63.33% [1]